Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes

Physiological Reports

Volumn 3, Issue 1, 2015, Pages

  Santillan, Mark K ^a,b   Pelham, Christopher J ^a   Ketsawatsomkron, Pimonrat ^a   Santillan, Donna A ^a,b   Davis, Deborah R ^a   Devor, Eric J ^a   Gibson Corle, Katherine N ^a   Scroggins, Sabrina M ^a   Grobe, Justin L ^a,b   Yang, Baoli ^a   Hunter, Steven K ^a   Sigmund, Curt D ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

3 dioxygenase; Animal model; Indoleamine 2; Preeclampsia; T cell

Indexed keywords

ACETYLCHOLINE; INDOLEAMINE 2,3 DIOXYGENASE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART RATE; HISTOLOGY; INTRAUTERINE GROWTH RETARDATION; KIDNEY PARENCHYMA; MESENTERIC ARTERY; MOUSE; NONHUMAN; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; TELEMETRY;

EID: 84992329274     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12257     Document Type: Article

References (36)

1. Baban, B., P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, et al. 2009. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183:2475-2483.
2. Chen, G., R. Wilson, S. H. Wang, H. Z. Zheng, J. J. Walker, and J. H. McKillop. 1996. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol. 104:154-159.
3. Dekker, G., and P. Y. Robillard. 2003. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J. Reprod. Immunol. 59: 245-251.
4. Godfrey, K. M. 2002. The role of the placenta in fetal programming-a review. Placenta 23(Suppl A):S20-S27.
5. Halabi, C. M., A. M. Beyer, W. J. de Lange, H. L. Keen, G. L. Baumbach, F. M. Faraci, et al. 2008. Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab. 7:215-226.
6. Hubel, C. A. 1999. Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med. 222:222-235.
7. Hunter, S. K. A. M., B. Yang, J. Whitham, J. Beck, and V. C. Sheffield. 2000. Society for Gynecologic Investigation 47th annual meeting. Chicago, Illinois, USA. March 22-25, 2000. Abstracts: decreased placental indoleamine 2,3-dioxygenase (IDO) activity in preeclamptic pregnancies. J. Soc. Gynecol. Investig. 7:43A-379A.
8. Kamimura, S., K. Eguchi, M. Yonezawa, and K. Sekiba. 1991. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med. Okayama 45:135-139.
9. Ketsawatsomkron, P., R. A. Lorca, H. L. Keen, E. T. Weatherford, X. Liu, C. J. Pelham, et al. 2012. PPARgamma regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity. Circ. Res. 111:1446-1458.
10. Kudo, Y., C. A. Boyd, I. L. Sargent, and C. W. Redman. 2000. Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi. Mol. Hum. Reprod. 6:369-374.
11. Kudo, Y., C. A. Boyd, I. L. Sargent, and C. W. Redman. 2003. Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. Am. J. Obstet. Gynecol. 188:719-726.
12. Kuklina, E. V., C. Ayala, and W. M. Callaghan. 2009. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet. Gynecol. 113:1299-306.
13. Lavoie, J. L., X. Liu, R. A. Bianco, T. G. Beltz, A. K. Johnson, and C. D. Sigmund. 2006. Evidence supporting a functional role for intracellular renin in the brain. Hypertension 47:461-466.
14. Liu, X., Y. Liu, M. Ding, and X. Wang. 2011. Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells. Mol. Med. Rep. 4:53-58.
15. Mellor, A. L., and D. H. Munn. 2001. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin. Immunol. 13:213-218.
16. Mellor, A. L., J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Mao, et al. 2001. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:64-68.
17. Munn, D. H., J. Pressey, A. C. Beall, R. Hudes, and M. R. Alderson. 1996. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion. J. Immunol. 156:523-532.
18. Munn, D. H., M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, et al. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193.
19. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1363-1372.
20. Myatt, L., W. Kossenjans, R. Sahay, A. Eis, and D. Brockman. 2000. Oxidative stress causes vascular dysfunction in the placenta. J. Matern. Fetal Med. 9:79-82.
21. Need, J. A. 1975. Pre-eclampsia in pregnancies by different fathers: immunological studies. Br. Med. J. 1:548-549.
22. Nishizawa, H., K. Hasegawa, M. Suzuki, S. Kamoshida, T. Kato, K. Saito, et al. 2007. The etiological role of allogeneic fetal rejection in pre-eclampsia. Am. J. Reprod. Immunol. 58:11-20.
23. Norwitz, E. R., D. J. Schust, and S. J. Fisher. 2001. Implantation and the survival of early pregnancy. N. Engl. J. Med. 345:1400-1408.
24. Redman, C. W., G. P. Sacks, and I. L. Sargent. 1999. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180:499-506.
25. Roberts, J. M., and C. A. Hubel. 1999. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354:788-789.
26. Robillard, P. Y., G. A. Dekker, and T. C. Hulsey. 1999. Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity? Eur. J. Obstet. Gynecol. Reprod. Biol. 84:37-41.
27. Saftlas, A. F., R. J. Levine, M. A. Klebanoff, K. L. Martz, M. G. Ewell, C. D. Morris, et al. 2003. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am. J. Epidemiol. 157:1108-1114.
28. Santillan, M. K., D. A. Santillan, S. M. Scroggins, J. Y. Min, J. A. Sandgren, N. A. Pearson, et al. 2014. Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension 64:852-859.
29. Santoso, D. I., P. Rogers, E. M. Wallace, U. Manuelpillai, D. Walker, and S. B. Subakir. 2002. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta 23: 373-379.
30. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, et al. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117:2570-2582.
31. Suzuki, S., S. Tone, O. Takikawa, T. Kubo, I. Kohno, and Y. Minatogawa. 2001. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem. J. 355:425-429.
32. Swamy, G. K., T. Ostbye, and R. Skjaerven. 2008. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 299:1429-1436.
33. Tatsumi, K., T. Higuchi, H. Fujiwara, T. Nakayama, H. Egawa, K. Itoh, et al. 2000. Induction of tryptophan 2,3-dioxygenase in the mouse endometrium during implantation. Biochem. Biophys. Res. Commun. 274:166-170.
34. Taylor, M. W., V. K. Konan, and D. Yu. 1996. Tryptophan starvation is involved in human interferon-gamma mediated apoptosis. Adv. Exp. Med. Biol. 398:155-159.
35. Thomas, S. R., and R. Stocker. 1999. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep. 4:199-220.
36. Zenclussen, A. C., S. Fest, R. Joachim, B. F. Klapp, and P. C. Arck. 2004. Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur. J. Immunol. 34:377-387.